Skip to content

Smoking is the biggest risk factor for non-AIDS-defining cancers in people living with HIV

Varenicline helps people with HIV stop smoking, but success rate remains low

Patrick Mercie presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

HIV attachment inhibitor BMS-663068 safe and effective in phase 2b study

Deferring hepatitis C treatment can lead to liver cancer and death, despite cure

Cindy Zahnd presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Progression to severe fibrosis or cirrhosis is common among baby boomers with hepatitis C in the US

Monina Klevens presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Study finds high rates of cancer among older people living with HIV

Panel including Elizabeth Yanik and Matthias Egger, at CROI 2015. Photo credit: Robb Cohen www.RobbsPhotos.com.

Levels of maraviroc in vaginal and rectal tissues may not be high enough for pre-exposure prophylaxis

Julie Fox presenting at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Financial incentives did not improve linkage to care or viral suppression in US study

Waafa El Sadr at CROI 2015. Photo by Liz Highleyman, hivandhepatitis.com

Tenofovir, boosted atazanavir and boosted lopinavir are associated with cumulative risk of developing chronic kidney disease